A Day Up For Auris Medical Holding Ltd.
Tue, Dec 01, 2020 at 05:32 PM
Auris Medical Holding Ltd. (EARS:NASDAQ) rocketted at $5.23, representing a gain of 371.2%. On Mon 30 Nov 20, EARS:NASDAQ touched a New 2-Week Intraday High of $1.21. The stock got featured on our News Catalysts scanner on Tue 01 Dec 20 at 10:43 AM in the 'BIOTECH' category. From Mon 16 Nov 20, the stock recorded 66.67% Up Days and 50.00% Green Days
The stock spiked on Thu 03 Sep 20 at $1.4 with a volume of 57M+, and its share price has been moving sideways in recent weeks.
About Auris Medical Holding Ltd. (EARS:NASDAQ)
Auris Medical Holding AG is a clinical-stage biopharmaceutical company. It is engaged in the development of novel products for the treatment of inner ear disorders. Its product candidate is AM-101.
Top 10 Gainers:
- Auris Medical Holding Ltd. (EARS:NASDAQ), 371.17%
- STWO (STWO:NASDAQ), 100%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 54.32%
- TDH Holdings, Inc. (PETZ:NASDAQ), 53.79%
- Corporacion America Airports S.A. (CAAP:NYSE), 42.99%
- DIRTT Environmental Solutions Ltd. (DRTT:NASDAQ), 32.93%
- Arlo Technologies, Inc. (ARLO:NYSE), 31.18%
- Jaguar Health, Inc. (JAGX:NASDAQ), 30.89%
- CollPlant Biotechnologies Ltd. (CLGN:NASDAQ), 29%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 28.45%